Funding This study was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Acknowledgments At the time of development of this manuscript, Fen Ye was an employee of Sanofi and Yufang Lu was an employee of Regeneron Pharmaceuticals.Medical writing support was provided by Abby Armitt, MSc, and Gauri Saal, MA Economics, of Prime, Knutsford, UK, and funded by Sanofi and Regeneron Pharmaceuticals, Inc.Peer reviewedPublisher PD
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this pap...
Rationale: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and likely includ...
Background: Type 2 inflammation underlies the chronicity of disease in subgroups of patients with as...
David Price,1,2 Andrew Menzies-Gow,3 Claus Bachert,4 Giorgio Walter Canonica,5 Janwillem Kocks,1 Asi...
Background: Although prevalence of co-existing type 2 inflammatory diseases (cT2) in asthma patients...
RATIONALE: Previous studies investigating comorbidity impact on biologic effectiveness have been rel...
Rationale: Studies have suggested some asthma patients are at risk of severe COVID-19, but they have...
The concept of the unified allergic airway disease (UAD) recognises the association between allergic...
Q2Q2Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COP...
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
Publisher Copyright: © 2023 The Authors. Clinical and Translational Allergy published by John Wiley ...
Rationale: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and likely includ...
This study was sponsored by Boehringer Ingelheim Ltd UK, which was involved in all stages of the stu...
© 2017 Turturice et al. This is an open access article distributed under the terms of the Creative C...
Asthma is a chronic inflammatory disease characterised by airflow obstruction and reversibility. The...
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this pap...
Rationale: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and likely includ...
Background: Type 2 inflammation underlies the chronicity of disease in subgroups of patients with as...
David Price,1,2 Andrew Menzies-Gow,3 Claus Bachert,4 Giorgio Walter Canonica,5 Janwillem Kocks,1 Asi...
Background: Although prevalence of co-existing type 2 inflammatory diseases (cT2) in asthma patients...
RATIONALE: Previous studies investigating comorbidity impact on biologic effectiveness have been rel...
Rationale: Studies have suggested some asthma patients are at risk of severe COVID-19, but they have...
The concept of the unified allergic airway disease (UAD) recognises the association between allergic...
Q2Q2Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COP...
Funding: ISAR is conducted by Optimum Patient Care Global Ltd, and co-funded by OPC Global Ltd and A...
Publisher Copyright: © 2023 The Authors. Clinical and Translational Allergy published by John Wiley ...
Rationale: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and likely includ...
This study was sponsored by Boehringer Ingelheim Ltd UK, which was involved in all stages of the stu...
© 2017 Turturice et al. This is an open access article distributed under the terms of the Creative C...
Asthma is a chronic inflammatory disease characterised by airflow obstruction and reversibility. The...
The International Primary Care Respiratory Group (IPCRG) has facilitated the publication of this pap...
Rationale: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and likely includ...
Background: Type 2 inflammation underlies the chronicity of disease in subgroups of patients with as...